Zobrazeno 1 - 3
of 3
pro vyhledávání: '"E. Gabriella Chiorean"'
Autor:
Matthew Burns, John T. Salter, Olumide B. Gbolahan, E. Gabriella Chiorean, Patrick J. Loehrer, Constantin T. Yiannoutsos, Ryan F. Porter
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 13(12)
Introduction Thymoma and thymic carcinoma (TC) are neoplastic diseases with reported chemosensitivity to a broad range of agents. However, because of the rarity of these diseases, few prospective trials have been conducted in patients with advanced t
Autor:
A. Ricart, E. Gabriella Chiorean, James J. Schlesselman, Khaled A. Tolba, Joseph D. Rosenblatt, Luis E. Raez, Kyriakos P. Papadopoulos, Metin Kurtoglu, Robert S. DiPaola, Donald Jung, Stewart Kroll, Mark N. Stein, V. K. Langmuir, Caio Max S. Rocha Lima, Theodore J. Lampidis
Publikováno v:
Cancer Chemotherapy and Pharmacology. 71:523-530
This phase I trial was initiated to evaluate the safety, pharmacokinetics (PK) and maximum tolerated dose (MTD) of the glycolytic inhibitor, 2-deoxy-D-glucose (2DG) in combination with docetaxel, in patients with advanced solid tumors.A modified acce
Autor:
Romnee Clark, A. John Spittler, Safi Shahda, E. Gabriella Chiorean, Sandra K. Althouse, Patrick J. Loehrer
Publikováno v:
The Oncologist
Lessons Learned Combination therapies in patients with hepatocellular carcinoma can be associated with overlapping toxicity and are therefore poorly tolerated. Using sorafenib at the maximum tolerated dose can lead to a higher incidence of toxicities